AURIMOD GmbH
PrivateLast Round
Grant
Oct 1, 2019
Total Funding Raised
$2.43M
Momentum
Top 50%
of companies Caplight tracks
Company Overview
AURIMOD GmbH operates in Healthcare & Life Sciences and is based in Vienna. Its latest recorded funding round was a Grant round in October 2019.
AURIMOD GmbH is a medical technology company that develops wearable neuromodulation devices for the personalized, non-pharmacological treatment of chronic pain.
Sector
Healthcare & Life Sciences
Verticals
Medical Devices, Health IoT
Business Model
B2B
Customer Profile
Hardware Sales, Services & Consulting
AI Layer
Application
Historical Pricing
Historical view of private secondary pricing and transaction trends.
AURIMOD GmbH Comparables
Compare AURIMOD GmbH with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| Soterix Medical | 79% | |
| Parasym | 79% | |
| JBA Health | 76% |
For institutional investors. Book with your work email.
AURIMOD GmbH Funding Rounds
Historical fundraising activity
For institutional investors. Book with your work email.
Key People
Founding team and executive leadership
For institutional investors. Book with your work email.
AURIMOD GmbH Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| ILUM Tec | Early Funding |
| European Union | Grant |
Market signals
Structured signals derived from secondary market and firmographic data.
- Jul 24, 2026
Monthly visitors grew 439% MoM, from 241 to 1.3K.
- Nov 16, 2025
Grew 31% QoQ, from 13 to 17 employees.
For institutional investors. Book with your work email.
Recent news
Latest coverage and updates
- recognized_asNov 12, 2026
KPMG Private Enterprise names Aurimod Gmbh the 2026 Global Tech Innovator winner at its global competition in Lisbon, Portugal, on Nov 11th '26, after it pitches among 18 national winners.
- receives_awardSep 30, 2026
Aurimod Gmbh wins the Austrian Tech Innovator 2026, organized by KPMG, through the audience vote for its wearable neurostimulation device for drug-free pain therapy.
For institutional investors. Book with your work email.
AURIMOD GmbH Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Book a demoFor institutional investors. Book with your work email.
Frequently Asked Questions
Common questions about AURIMOD GmbH's valuation, stock price, and market status.
Is AURIMOD GmbH a public or private company?
AURIMOD GmbH is a private company.
What is the current stock price of AURIMOD GmbH?
AURIMOD GmbH is a private company, so its shares have no public market price. Caplight tracks AURIMOD GmbH's secondary market activity and provides MarketPrice™ estimates of its share price to Caplight users.
How much is AURIMOD GmbH worth (valuation)?
Valuation information for AURIMOD GmbH is not publicly available.
Can I buy AURIMOD GmbH stock?
AURIMOD GmbH shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors.
When was AURIMOD GmbH's last funding round?
AURIMOD GmbH's most recent funding round was Grant on October 1, 2019.
Who are the main investors in AURIMOD GmbH?
Key investors in AURIMOD GmbH include ILUM Tec, European Union.
Will AURIMOD GmbH IPO soon?
No public IPO plans have been announced for AURIMOD GmbH.
How can I track AURIMOD GmbH secondary market activity?
Caplight tracks bids, offers, and trades in AURIMOD GmbH's shares on secondary markets.